Our discovery of a link between N-Myc and lif in neuroblastoma also suggests a possible new treatment for neuroblastoma in the form of LIF antagonists that would be predicted to induce regression through stimulating differentiation (Fig. 6). This evidence concerns the gene MYCN and neuroblastoma.